October 24, 2022 Comments Off on New patent expiration for Organon drug SINGULAIR Posted in: Uncategorized
Annual Drug Patent Expirations for SINGULAIR Singulair is a drug marketed by Organon and is included in three NDAs. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Organon drug SINGULAIR appeared first …
October 22, 2022 Comments Off on New patent expiration for Braintree drug HALFLYTELY Posted in: Uncategorized
Annual Drug Patent Expirations for HALFLYTELY Halflytely is a drug marketed by Braintree and is included in one NDA. There is one patent protecting this drug and two Paragraph IV…
The post New patent expiration for Braintree drug HALFLYTELY appeared fi…